Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03477643
Recruitment Status : Recruiting
First Posted : March 26, 2018
Last Update Posted : November 5, 2019
Information provided by (Responsible Party):
PETHEMA Foundation

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 13, 2019
Estimated Study Completion Date : December 13, 2019